149 related articles for article (PubMed ID: 16428788)
1. Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization.
Miyamoto T; Yumoto H; Takahashi Y; Davey M; Gibson FC; Genco CA
Infect Immun; 2006 Feb; 74(2):1376-80. PubMed ID: 16428788
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs.
Gibson FC; Genco CA
Curr Pharm Des; 2007; 13(36):3665-75. PubMed ID: 18220804
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice.
Pan S; Lei L; Chen S; Li H; Yan F
Int Immunopharmacol; 2014 Dec; 23(2):701-8. PubMed ID: 25445963
[TBL] [Abstract][Full Text] [Related]
4. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.
Gibson FC; Hong C; Chou HH; Yumoto H; Chen J; Lien E; Wong J; Genco CA
Circulation; 2004 Jun; 109(22):2801-6. PubMed ID: 15123526
[TBL] [Abstract][Full Text] [Related]
5. Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses.
Hayashi C; Madrigal AG; Liu X; Ukai T; Goswami S; Gudino CV; Gibson FC; Genco CA
J Innate Immun; 2010; 2(4):334-43. PubMed ID: 20505314
[TBL] [Abstract][Full Text] [Related]
6. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with Porphyromonas gingivalis and atherosclerosis.
Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
Immunopharmacol Immunotoxicol; 2009; 31(3):352-7. PubMed ID: 19555215
[TBL] [Abstract][Full Text] [Related]
8. Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis.
Cai Y; Kurita-Ochiai T; Hashizume T; Yamamoto M
Pathog Dis; 2013 Feb; 67(1):76-83. PubMed ID: 23620122
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis Infection Accelerates Atherosclerosis Mediated by Oxidative Stress and Inflammatory Responses in ApoE-/- Mice.
Xuan Y; Shi Q; Liu GJ; Luan QX; Cai Y
Clin Lab; 2017 Oct; 63(10):1627-1637. PubMed ID: 29035447
[TBL] [Abstract][Full Text] [Related]
10. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.
Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
Infect Immun; 2008 Jul; 76(7):2958-65. PubMed ID: 18426881
[TBL] [Abstract][Full Text] [Related]
11. Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.
Slocum C; Coats SR; Hua N; Kramer C; Papadopoulos G; Weinberg EO; Gudino CV; Hamilton JA; Darveau RP; Genco CA
PLoS Pathog; 2014 Jul; 10(7):e1004215. PubMed ID: 25010102
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
Chi H; Messas E; Levine RA; Graves DT; Amar S
Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in systemic inflammation and atheroma formation following Porphyromonas gingivalis infection in heterozygous apolipoprotein E-deficient mice.
Champagne C; Yoshinari N; Oetjen JA; Riché EL; Beck JD; Offenbacher S
J Periodontal Res; 2009 Oct; 44(5):569-77. PubMed ID: 18973527
[TBL] [Abstract][Full Text] [Related]
14. Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications.
Amar S; Wu SC; Madan M
J Immunol; 2009 Feb; 182(3):1584-92. PubMed ID: 19155507
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice.
Hayashi C; Viereck J; Hua N; Phinikaridou A; Madrigal AG; Gibson FC; Hamilton JA; Genco CA
Atherosclerosis; 2011 Mar; 215(1):52-9. PubMed ID: 21251656
[TBL] [Abstract][Full Text] [Related]
16. Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen.
Hayashi C; Papadopoulos G; Gudino CV; Weinberg EO; Barth KR; Madrigal AG; Chen Y; Ning H; LaValley M; Gibson FC; Hamilton JA; Genco CA
J Immunol; 2012 Oct; 189(7):3681-8. PubMed ID: 22956579
[TBL] [Abstract][Full Text] [Related]
17. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model.
Li L; Messas E; Batista EL; Levine RA; Amar S
Circulation; 2002 Feb; 105(7):861-7. PubMed ID: 11854128
[TBL] [Abstract][Full Text] [Related]
18. [Effect of longterm lower Porphyromonas gingivalis infection on the progression of atherosclerosis in apolipoprotein E-knocked out mice].
Tang XN; Wu J; Sun WB
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Feb; 46(2):75-8. PubMed ID: 21426774
[TBL] [Abstract][Full Text] [Related]
19. Hyperlipidemia impaired innate immune response to periodontal pathogen porphyromonas gingivalis in apolipoprotein E knockout mice.
Lei L; Li H; Yan F; Xiao Y
PLoS One; 2013; 8(8):e71849. PubMed ID: 23977160
[TBL] [Abstract][Full Text] [Related]
20. Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.
Kyrklund M; Kummu O; Kankaanpää J; Akhi R; Nissinen A; Turunen SP; Pussinen P; Wang C; Hörkkö S
PLoS One; 2018; 13(1):e0191216. PubMed ID: 29329335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
